Together we Drive the Future

Next Generation Sequencing

EARLY BIRD DISCOUNT! Register by Jul 26, 2017 to receive 20% off your registration!
Or Register 3 for the price of 2 with the coupon code rcdvb!

registration button

Genomics & Big Data Summit

Metabolomics - Advances & Applications in Human Disease

Next Generation Sequencing

Big Data Bioinformatics

CRISPR & Genome Engineering

Subscribe for updates

Dear Colleague,

We invite you to attend the Next Generation Sequencing Conference, which is part of The Genomics & Big Data Summit and takes place in September 26-27, 2017.

Next generation sequencing has made it possible to obtain genetic information from biological systems by rapid and inexpensive methods. Therefore, the ability to analyze genomes and protein interactions has been accomplished. Now, the branches of next generation sequencing has expanded to single cell analyses, RNA sequencing approaches, and discoveries in the microbiome space. The race for faster, cheaper, and higher precision sequencing approaches has been a constant goal for researchers so that there are improved methods in this field.

This meeting will provide attendees with a better understanding of developments in new next generation sequencing technologies alongside clinical applications. There will be a focus on medical sequencing for patient characterization in targeted therapies through vast methods like single cell and RNA sequencing. Implications for how diseases should be treated will be discussed through the examination of data produced from reputable assays.

Joint Plenary Sessions:

  1. Opening Keynote Session – Historical Perspective & Current State of the Industry
  2. Round Table Discussions 
  3. Lunch Session – Ethical Challenges of Big Data and Genomics Application
  4. Award Ceremony & Closing Keynote Session – Predictions for the Future

Next Generation Sequencing:

  1. RNA and DNA Sequencing including Single Cell Analysis
  2. Clinical Diagnostic Sequencing and Emerging Technologies


We hope to see you there!

Best regards,

The 2017 Advisory Committee